Health Care, 3 Other S&P Sectors at All-time Highs as Index Edges Closer to Fresh Peak
Looking At Broadcom's Recent Unusual Options Activity
Decoding Eli Lilly's Options Activity: What's the Big Picture?
Nutanix Spikes as It Takes Advantage of VMware Acquisition by Broadcom
Tsinghua University's president has served as the chief scientist. Pinchi Medical has initiated IPO counseling, with investment from Gao Ling, Eli Lilly and Junlian.
1. Healthily Medical has initiated IPO counseling, with China International Capital Corporation as the consulting institution; 2. Healthily Medical's neuroregulation products such as brain pacemakers have broken the monopoly in the United States; 3. Healthily Medical's planned listing sector may be the STAR board.
New Medicare Drug Price Caps Could Help Seniors Save Over $1,000 a Year - AARP
Here's How Much $1000 Invested In Eli Lilly 10 Years Ago Would Be Worth Today
NetApp And Broadcom Enhance VMware Cloud Foundation Deployments, Introducing New Capabilities To Optimize Private And Hybrid Cloud Environments; Continued Collaboration Ensures Efficient Scaling And Performance For Joint Customers
Stocks Hitting All-time Highs: JPM, KO, LMT, UNH, and More
10 Industrials Stocks With Whale Alerts In Today's Session
NVIDIA's Earnings: 5 Reasons Why This Week's Report Could Shake Up Markets, AI Stocks, And The S&P 500
Texas Instruments, Dell, Intel Likely to Make News at Conference Next Month: Citi
Nvidia Set To Become The Hub Of AI Ecosystem, Similar To Amazon's Dominance In E-Commerce, Says Expert Ahead Of Q2 Earnings
Eli Lilly's self-operated website has launched a "small cup" weight loss drug, priced at only about half of the price of the base model.
Eli Lilly and Co. has announced that the low-dose version of Zepbound (telbivudine injection) has been launched in the USA. Patients can purchase it on Eli Lilly's self-operated website, LillyDirect. The price for a single dose of 2.5 milligrams is $399 for a four-week treatment, while the 5 milligram version is priced at $549, which is nearly a 50% discount from the original price.
FDA Approves Illumina's TruSight Oncology Biomarker Test
Dow Hits Closing High as Market Holds On to Records | Wall Street Today
Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna
Sanders To Press Eli Lilly On Cutting Costs For Weight Loss Drugs
What's Going On With Broadcom Shares Tuesday?
Dow Cautious at All-Time High, Market Holding Its Breath